about
Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylationDiNAMIC: a method to identify recurrent DNA copy number aberrations in tumorsMYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma.Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment.Integrated RNA and DNA sequencing improves mutation detection in low purity tumors.BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization.Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes.Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.Integrated Molecular Characterization of Uterine Carcinosarcoma.Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC.High XRCC1 protein expression is associated with poorer survival in patients with head and neck squamous cell carcinoma.FOXA1, GATA3 and PPARɣ Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines.Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitinationAltered molecular profile in thyroid cancers from patients affected by the Three Mile Island nuclear accident.Autologous reconstitution of human cancer and immune system in vivo.Gene silencing associated with SWI/SNF complex loss during NSCLC development.Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.Hedgehog-GLI signaling inhibition suppresses tumor growth in squamous lung cancer.Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer.Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors.MVisAGe identifies concordant and discordant genomic alterations of driver genes in squamous tumors.Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic VariantsGene Expression Subtype Predicts Nodal Metastasis and Survival in Human Papillomavirus-Negative Head and Neck CancerFrequent HPV-independent p16/INK4A overexpression in head and neck cancerEvidence of a positive association between malpractice climate and thyroid cancer incidence in the United StatesUnraveling the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) expression in colon carcinogenesisHypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancerRepression of transcription factor AP-2 alpha by PPARγ reveals a novel transcriptional circuit in basal-squamous bladder cancerThe native ORAI channel trio underlies the diversity of Ca2+ signaling eventsAn integrated approach for preventing oral cavity and oropharyngeal cancers: two etiologies with distinct and shared mechanisms of carcinogenesis
P50
Q28730029-65FE5F27-9056-4DD2-BEED-46195F332178Q30498218-7679420E-4EA7-4ED3-BA83-73A4D9093C67Q33804675-7B0F2DFB-916B-4C55-99A4-70AFF819370AQ33849590-FE03C781-61C3-4C85-B0EA-F716DF31727AQ33983489-5DDB4779-0412-44EB-AC96-5D10D2F3D92AQ34518491-C46E0553-8EC7-4649-9026-8B35E6B7E8BBQ34602664-29194FAB-8EF7-405F-88E8-963F84952B77Q34680693-B8AD9A72-A7A1-4255-BCA2-B17A70A8840BQ34681051-B30B4AA6-7084-4483-AEC2-593E48E4789EQ35664233-8595F85B-8550-4BA9-8CBF-E5072A1539F3Q37050088-8CC31855-E93A-4D79-9348-C84969AFCEF9Q37479778-310D941D-1F27-48CE-B73C-FCFA55BA9002Q37599046-3240E0DB-B2F5-4C1A-BBCA-32DD63E5368EQ38757570-58792746-21BE-41A1-832E-3934455DB167Q38779010-0A3590F7-D39D-4D45-BD0B-6911EB6905D6Q38794787-CE0816DA-895D-4D7F-969E-89691A3D72B6Q40082486-8313483F-0361-43A7-80CD-FCB1ED37629CQ42803574-B8C87D25-53DA-4A73-86A4-D844A5EBAD45Q47120183-6DF593F7-0FD8-4DEC-92A4-6D5852679E9FQ51763437-F4FD0AB1-6948-4875-9457-D2302198213EQ52560374-9EA4B8A9-D9DC-455A-9245-C303EB6BD288Q52607328-454B477D-18FF-408F-80D6-DC2A84916958Q57130277-3BFB1457-979A-4E38-B21E-951D67AB7579Q57151815-7B67D2A6-4275-4F6D-B334-0A7024EADFA2Q58804797-8002918D-3D6E-413F-BE18-729569C7D49AQ90315288-546056FC-30BC-46E4-A1BA-BF6025EF5AE4Q90644328-4D2B65CF-C158-422E-8D9C-2CA187908C32Q90859705-A6929933-1891-4A0D-B04D-D7E904B3D2CCQ91473403-9AAED08B-E515-4A66-90E6-E0F56CE831F1Q94948208-8135B711-0DCC-4DED-B2A7-BD16D7A6B20BQ95336032-D17A1F64-190C-4FDD-A48B-C3D5C830AB5B
P50
description
researcher, ORCID id # 0000-0001-6114-6714
@en
wetenschapper
@nl
name
Vonn Walter
@ast
Vonn Walter
@en
Vonn Walter
@es
Vonn Walter
@nl
type
label
Vonn Walter
@ast
Vonn Walter
@en
Vonn Walter
@es
Vonn Walter
@nl
prefLabel
Vonn Walter
@ast
Vonn Walter
@en
Vonn Walter
@es
Vonn Walter
@nl
P106
P1153
36936192700
P31
P496
0000-0001-6114-6714